Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 21, 2014, Pages 7594-7599

  Wiita, Arun P ^a,b   Hsu, Gerald W ^c   Lu, Chuanyi M ^a,c   Esensten, Jonathan H ^a   Wells, James A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; BORTEZOMIB; CYTARABINE; CYTOKERATIN; CYTOKERATIN 18; DOXORUBICIN; GELSOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; VIMENTIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LARGE CELL LYMPHOMA; MASS SPECTROMETRY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEOMICS;

ACTIVATING TRANSCRIPTION FACTOR 6; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MASS SPECTROMETRY; MITOCHONDRIAL PROTEINS; PEPTIDE FRAGMENTS; PROTEOLYSIS; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84901659491     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1405987111     Document Type: Article

References (32)

1. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256(1):42-49. (Pubitemid 30211165)
2. Blankenberg FG (2008) In vivo imaging of apoptosis. Cancer Biol Ther 7(10): 1525-1532.
3. Renz A, et al. (2001) Rapid extracellular release of cytochrome c is specific for apo-ptosis and marks cell death in vivo. Blood 98(5):1542-1548.
4. Moffitt KL, Martin SL, Walker B (2010) Proteases implicated in apoptosis: Old and new. J Pharm Pharmacol 62(5):563-576.
5. Crawford ED, Wells JA (2011) Caspase substrates and cellular remodeling. Annu Rev Biochem 80:1055-1087.
6. Yang TJ, Haimovitz-Friedman A, Verheij M (2012) Anticancer therapy and apoptosis imaging. Exp Oncol 34(3):269-276.
7. Beachy SH, Repasky EA (2008) Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: An update. Cancer Immunol Immunother 57(6):759-775.
8. Greystoke A, et al. (2011) Assessment of circulating biomarkers for potential phar-macodynamic utility in patients with lymphoma. Br J Cancer 104(4):719-725.
9. Olofsson MH, et al. (2007) Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin Cancer Res 13(11):3198-3206. (Pubitemid 46944902)
10. Dean E, Greystoke A, Ranson M, Dive C (2012) Biomarkers of cell death applicable to early clinical trials. Exp Cell Res 318(11):1252-1259.
11. Mahrus S, et al. (2008) Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134(5):866-876.
12. Wildes D, Wells JA (2010) Sampling the N-terminal proteome of human blood. Proc Natl Acad Sci USA 107(10):4561-4566.
13. Wiita AP, Seaman JE, Wells JA, Global analysis of cellular proteolysis by selective enzymatic labeling of protein N-termini. Methods Enzymol, in press.
14. Polevoda B, Sherman F (2003) N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J Mol Biol 325(4):595-622. (Pubitemid 36268685)
15. Gerszten RE, et al. (2008) Challenges in translating plasma proteomics from bench to bedside: Update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol 295(1):L16-L22.
16. Addona TA, et al. (2011) A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol 29(7):635-643.
17. Whiteaker JR, et al. (2011) A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 29(7):625-634.
18. Crawford ED, et al. (2013) The DegraBase: A database of proteolysis in healthy and apoptotic human cells. Mol Cell Proteomics 12(3):813-824.
19. Picotti P, Aebersold R (2012) Selected reaction monitoring-based proteomics: Workflows, potential, pitfalls and future directions. Nat Methods 9(6):555-566.
20. Saelens X, et al. (2004) Toxic proteins released from mitochondria in cell death. On-cogene 23(16):2861-2874. (Pubitemid 38638848)
21. Haze K, Yoshida H, Yanagi H, Yura T, Mori K (1999) Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10(11):3787-3799. (Pubitemid 29534025)
22. Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68(18):3033-3046.
23. Crawford ED, et al. (2012) Conservation of caspase substrates across metazoans suggests hierarchical importance of signaling pathways over specific targets and cleavage site motifs in apoptosis. Cell Death Differ 19(12):2040-2048.
24. Shimbo K, et al. (2012) Quantitative profiling of caspase-cleaved substrates reveals different drug-induced and cell-type patterns in apoptosis. Proc Natl Acad Sci USA 109(31):12432-12437.
25. Jaffe JD, et al. (2008) Accurate inclusion mass screening: A bridge from unbiased discovery to targeted assay development for biomarker verification. Mol Cell Pro-teomics 7(10):1952-1962.
26. Agard NJ, et al. (2012) Global kinetic analysis of proteolysis via quantitative targeted proteomics. Proc Natl Acad Sci USA 109(6):1913-1918.
27. Bucki R, Levental I, Kulakowska A, Janmey PA (2008) Plasma gelsolin: Function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 9(6):541-551.
28. Wang M, et al. (2012) PaxDb, a database of protein abundance averages across all three domains of life. Mol Cell Proteomics 11(8):492-500.
29. Picotti P, et al. (2010) High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 7(1):43-46.
30. Wiita AP, et al. (2013) Global cellular response to chemotherapy-induced apoptosis. Elife 2:e01236.
31. Lote CJ (2012) Principles of Renal Physiology (Springer, New York), 5th Ed.
32. MacLean B, et al. (2010) Skyline: An open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26(7):966-968.